Job Summary
Job Purpose:
In this role, you will shape and drive regulatory strategies for biosimilar development and lifecycle management, enabling efficient submissions, approvals, and sustainable product maintenance across global markets.
You will own and execute regulatory strategies independently while coordinating cross-functional activities for high-quality submissions. Additionally, you will lead interactions with health authorities, ensure effective implementation of feedback, and proactively influence the evolving regulatory landscape.
Your Responsibilities:
Provide global regulatory leadership for biosimilar development and manage submission-related documents and data
Lead preparation, rehearsal and execution of meetings with Health Authorities (e.g. EMA, FDA)
Develop and drive global submission strategies for biosimilar dossiers across development and lifecycle phases
Ensure compliance with regulatory requirements across key markets (EU, US, Canada, Switzerland, Brazil)
Align and gain endorsement of regulatory strategies with Development Team and Biosimilar Management Team (BMT)
Define and deliver clear regulatory storylines for authority interactions (e.g. briefing books, submissions)
Collaborate with Regulatory Operations to implement technologies and ensure consistent systems and processes
Provide regulatory guidance to Market Units and support global launch and market prioritization decisions
Lead the Regulatory Sub-team and drive submissions through to approval, including readiness assessments
Act as key interface across regulatory and cross-functional teams, mentor team members and manage external partners
Similar Jobs
What you need to know about the Los Angeles Tech Scene
Key Facts About Los Angeles Tech
- Number of Tech Workers: 375,800; 5.5% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Snap, Netflix, SpaceX, Disney, Google
- Key Industries: Artificial intelligence, adtech, media, software, game development
- Funding Landscape: $11.6 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Strong Ventures, Fifth Wall, Upfront Ventures, Mucker Capital, Kittyhawk Ventures
- Research Centers and Universities: California Institute of Technology, UCLA, University of Southern California, UC Irvine, Pepperdine, California Institute for Immunology and Immunotherapy, Center for Quantum Science and Engineering



